Actuate Therapeutics Inc (ACTU) — Financial statements
Income statement, balance sheet, and cash flow for Actuate Therapeutics Inc — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | |||||
| R&D Expenses | 10↓44.9% | 19↓14.0% | 22↑32.5% | 16 | |
| General & Administrative Expenses | 12↑88.2% | 6↑98.6% | 3↓14.5% | 4 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 12↑88.2% | 6↑98.6% | 3↓14.5% | 4 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 22↓10.6% | 25↑0.7% | 25↑23.6% | 20 | |
| Total Costs & Expenses | 22↓10.6% | 25↑0.7% | 25↑23.6% | 20 | |
| Operating Results | |||||
| Operating Income | -22↑10.6% | -25↓0.7% | -25↓23.6% | -20 | |
| Depreciation & Amortization | 0.00↓100.0% | 2↑685.5% | 0.27↑329.0% | 0.06 | |
| EBITDA | -22↑10.6% | -25↓3.0% | -24↓21.7% | -20 | |
| EBIT | -22↑17.6% | -27↓10.5% | -25↓22.6% | -20 | |
| Interest & Other Income | |||||
| Net Interest Income | 0.27↑11.0% | 0.24↓22.0% | 0.31↑2754.3% | 0.01 | |
| Interest Income | 0.29↑29.4% | 0.22↓37.0% | 0.35↑1204.9% | 0.03 | |
| Interest Expense | 0.02↑208.2% | -0.02↓142.9% | 0.04↑169.4% | 0.02 | |
| Non-Operating Income | 0.00↓100.0% | 2↑885.5% | -0.27↓329.0% | -0.06 | |
| Other Income / Expenses | 0.27↑112.6% | -2↓1026.6% | 0.23↑383.5% | 0.05 | |
| Income Before Tax | -22↑18.5% | -27↓10.3% | -25↓22.7% | -20 | |
| Income Tax Expense | 0.00↓100.0% | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -22↑18.5% | -27↓10.3% | -25↓22.7% | -20 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -22↑18.5% | -27↓10.3% | -25↓22.7% | -20 | |
| Bottom-Line Net Income | -22↑18.5% | -27↓10.3% | -25↓22.7% | -20 | |
| EPS (Basic) | -1.06↑67.5% | -3.26↓97.6% | -1.65↓23.1% | -1.34 | |
| EPS (Diluted) | -1.06↑67.5% | -3.26↓97.6% | -1.65↓23.1% | -1.34 | |
| Weighted Average Shares | 21↑7.7% | 20↑29.8% | 15↑0.0% | 15 | |
| Weighted Average Diluted Shares | 21↑7.7% | 20↑29.8% | 15↑0.0% | 15 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.